Literature DB >> 27734161

Determinants for persistence of Pseudomonas aeruginosa in hospitals: interplay between resistance, virulence and biofilm formation.

S J Kaiser1, N T Mutters1, A DeRosa2, C Ewers3, U Frank1, F Günther4.   

Abstract

Pseudomonas aeruginosa (Pa) is one of the major bacterial pathogens causing nosocomial infections. During the past few decades, multidrug-resistant (MDR) and extensively drug-resistant (XDR) lineages of Pa have emerged in hospital settings with increasing numbers. However, it remains unclear which determinants of Pa facilitated this spread. A total of 211 clinical XDR and 38 susceptible clinical Pa isolates (nonXDR), as well as 47 environmental isolates (EI), were collected at the Heidelberg University Hospital. We used RAPD PCR to identify genetic clusters. Carriage of carbapenamases (CPM) and virulence genes were analyzed by PCR, biofilm formation capacity was assessed, in vitro fitness was evaluated using competitive growth assays, and interaction with the host's immune system was analyzed using serum killing and neutrophil killing assays. XDR isolates showed significantly elevated biofilm formation (p < 0.05) and higher competitive fitness compared to nonXDR and EI isolates. Thirty percent (62/205) of the XDR isolates carried a CPM. Similarities in distribution of virulence factors, as well as biofilm formation properties, between CPM+ Pa isolates and EI and between CPM- and nonXDR isolates were detected. Molecular typing revealed two distinct genetic clusters within the XDR population, which were characterized by even higher biofilm formation. In contrast, XDR isolates were more susceptible to the immune response than nonXDR isolates. Our study provides evidence that the ability to form biofilms is an outstanding determinant for persistence and endemic spread of Pa in the hospital setting.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27734161     DOI: 10.1007/s10096-016-2792-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  65 in total

Review 1.  Biofilms as complex differentiated communities.

Authors:  P Stoodley; K Sauer; D G Davies; J W Costerton
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

2.  Virulence gene distribution in clinical, nosocomial and environmental isolates of Pseudomonas aeruginosa.

Authors:  R S Bradbury; L F Roddam; A Merritt; D W Reid; A C Champion
Journal:  J Med Microbiol       Date:  2010-04-29       Impact factor: 2.472

3.  Analysis of a long-term outbreak of XDR Pseudomonas aeruginosa: a molecular epidemiological study.

Authors:  Matthias Willmann; Daniela Bezdan; Luis Zapata; Hana Susak; Wichard Vogel; Klaus Schröppel; Jan Liese; Christopher Weidenmaier; Ingo B Autenrieth; Stephan Ossowski; Silke Peter
Journal:  J Antimicrob Chemother       Date:  2015-01-11       Impact factor: 5.790

4.  Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAO1 in vivo.

Authors:  Russell E Vance; Arne Rietsch; John J Mekalanos
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

5.  Synthesis of multiple Pseudomonas aeruginosa biofilm matrix exopolysaccharides is post-transcriptionally regulated.

Authors:  Luyan Ma; Juan Wang; Shiwei Wang; Erin M Anderson; Joseph S Lam; Matthew R Parsek; Daniel J Wozniak
Journal:  Environ Microbiol       Date:  2012-04-19       Impact factor: 5.491

Review 6.  Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung.

Authors:  Michael Hogardt; Jürgen Heesemann
Journal:  Int J Med Microbiol       Date:  2010-10-12       Impact factor: 3.473

7.  A genotypic and phenotypic comparison of type III secretion profiles of Pseudomonas aeruginosa cystic fibrosis and bacteremia isolates.

Authors:  David W Wareham; Michael A Curtis
Journal:  Int J Med Microbiol       Date:  2007-04-06       Impact factor: 3.473

8.  Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis.

Authors:  C E Wainwright; M W France; P O'Rourke; S Anuj; T J Kidd; M D Nissen; T P Sloots; C Coulter; Z Ristovski; M Hargreaves; B R Rose; C Harbour; S C Bell; K P Fennelly
Journal:  Thorax       Date:  2009-07-01       Impact factor: 9.139

Review 9.  Pseudomonas Exotoxin A: optimized by evolution for effective killing.

Authors:  Marta Michalska; Philipp Wolf
Journal:  Front Microbiol       Date:  2015-09-15       Impact factor: 5.640

10.  Effects of human serum and apo-Transferrin on Staphylococcus epidermidis RP62A biofilm formation.

Authors:  Pengfei She; Lihua Chen; Yong Qi; Huan Xu; Yuan Liu; Yangxia Wang; Zhen Luo; Yong Wu
Journal:  Microbiologyopen       Date:  2016-05-16       Impact factor: 3.139

View more
  2 in total

1.  High Rates of Extensively Drug-Resistant Pseudomonas aeruginosa in Children with Cystic Fibrosis.

Authors:  Juan C Gutiérrez-Santana; Armando Gerónimo-Gallegos; Mónica B Martínez-Corona; Marisol López-López; Julia D Toscano-Garibay; Francisco Cuevas-Schacht; Victor R Coria-Jiménez
Journal:  Curr Microbiol       Date:  2022-10-08       Impact factor: 2.343

2.  Ability of chlorhexidine, octenidine, polyhexanide and chloroxylenol to inhibit metabolism of biofilm-forming clinical multidrug-resistant organisms.

Authors:  Frank Günther; Brigitte Blessing; Ulrike Dapunt; Alexander Mischnik; Nico T Mutters
Journal:  J Infect Prev       Date:  2020-10-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.